Medications

India court blocks Bayer generic drug appeal

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

Dec 13, 2014
popularity 5 / 5 (1) | comments 1

Drug shortage crisis puts public health at risk

Hospitals and pharmacies around the country are facing severe shortages of essential drugs. These shortages can limit access to critical medications and compromise patient safety, resulting in serious illness ...

Dec 11, 2014
popularity 5 / 5 (1) | comments 0

Daclatasvir for hepatitis C: Added benefit not proven

The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care (IQWiG) ...

Dec 10, 2014
popularity not rated yet | comments 0

Pricing for new drugs lacks transparency

The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal of ...

Dec 08, 2014
popularity not rated yet | comments 0

Correcting myths about the flu vaccine

December 8, 2014 - With health systems in the U.S., U.K., and around the world trying to increase vaccination levels, it is critical to understand how to address vaccine hesitancy and counter myths about vaccine safety. A ...

Dec 08, 2014
popularity 3 / 5 (2) | comments 0

Paralegal: Sanofi fired her for whistleblowing

(AP)—A paralegal recently fired by French drugmaker Sanofi has filed a whistleblower lawsuit, claiming she was discharged after protesting an alleged kickback scheme to increase U.S. sales of its medicines.

Dec 05, 2014
popularity not rated yet | comments 0